Silver Book Fact

Economics of DR Treatment

Fact image

Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.

Pershing S, Enns E, Matesic B, Owens D, et al. Cost-Effectiveness of Treatment of Diabetic Macular Edema. Ann Intern Med. 2014; 160(1): 160-3. http://annals.org/article.aspx?articleid=1811027

Reference

Title
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Publication
Ann Intern Med
Publication Date
2014
Authors
Pershing S, Enns E, Matesic B, Owens D, et al.
Volume & Issue
Volume 160, Issue 1
Pages
160-3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Laser treatments save up to $1.6 billion per year through prevention and treatment of blindness in diabetics.  
  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring, and collaborative drug therapy management…  
  • Every additional dollar spent on screening and treating diabetic eye disease in type 2 diabetics on insulin has produced health gains valued at $36.  
  • 150 drugs are in development for diabetes. Diabetes affects 12.2 million Americans age 60 and older.  
  • The cost effectiveness ratio for pump therapy compared with daily insulin injections is about $18,000 per life year saved.